Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.
about
The role of lipoxygenases in pathophysiology; new insights and future perspectivesThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolutionFunctional and pathological roles of the 12- and 15-lipoxygenasesProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeMacrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repairResolution, the grail for healthy ocular inflammation.Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesisEGF stimulates lipoxin A4 synthesis and modulates repair in corneal epithelial cells through ERK and p38 activation.Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.Inhibition of Corneal Inflammation by the Resolvin E1.Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the corneaFemale-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.Rapid induction of inflammatory lipid mediators by the inflammasome in vivo.Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Interleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model.Local TNFR1 Signaling Licenses Murine Neutrophils for Increased TLR-Dependent Cytokine and Eicosanoid Production.The role of pro-resolving lipid mediators in ocular diseases.Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways.Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface DisordersDry eye syndrome: developments and lifitegrast in perspective.Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I
P2860
Q26795652-9A731FAC-1889-4CB1-9213-2DA4FFC8EC78Q28260186-22FD848C-D6FF-4B58-8F2A-80A8A589249FQ28296453-06A9B63C-0C64-4EE0-8357-DB975CCED9EEQ28387661-55C896A2-9E3C-4023-998E-22409CB20B62Q28731852-083CE45F-3B04-4616-9343-3238333127F9Q34126362-4582C255-77A1-42CE-A002-34A31D761DFBQ34415658-12D23976-0822-4746-AACB-AE3C40DA4309Q34522097-5C4928D7-531B-404A-A5AC-405CDC05CF2AQ34586379-F8AF5F61-9E48-4BA7-B67D-404CDE1C9437Q34598738-7AB3B25C-AEC6-48BB-9918-544F47017C5BQ34662175-9E756AC1-CD92-45B7-AE02-2F55A92A3862Q34824077-7AE00995-AA65-4CC2-85E0-4A6CDCC9CAD5Q35024234-0A6D934D-4C8F-42C5-8C0F-3213631387D7Q35043902-159DE214-8EEA-4D00-980D-220CF21AFF8FQ35098090-8C73EB07-1BAE-4544-B39D-3192CA15B866Q35560054-15A3E5E1-4BE4-49F8-BB41-4DEB17B43AE7Q35863828-92B53F19-02B9-4675-8D68-C41ECDB4884AQ36075268-5D1523C9-6EF9-4331-85F3-3BBC4B2289D9Q36301040-B513318C-80A2-4F67-81CD-944FD1FD8851Q36375441-F17DB0F3-AEFE-4054-BD32-28856219C5CDQ36872931-AB6EF732-0603-410B-92DC-C5670E6F9A43Q37603197-E50B5D9B-A2F3-4BE9-866E-8FEEDD30D073Q38758046-B924F2F1-692F-457F-BDFE-FC90297899E6Q38951232-21743F6B-2EF2-462C-BC19-DB6A76094944Q39213940-84FDFE7C-3E6B-4A24-840D-58A63C372DDDQ40317977-21B33177-F4F2-4B55-80CD-0DCF7BAF252DQ41233563-978BB0B3-ED90-49CC-8231-C819BB31F30CQ41574217-CE19244F-A901-42D7-884C-490FDE8DB103Q47639135-84DD3609-D0BB-414A-ABF5-86F9601F9234Q56699407-453D9E31-DBDB-4264-84BF-DF8D0B809089
P2860
Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@ast
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@en
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@nl
type
label
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@ast
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@en
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@nl
prefLabel
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@ast
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@en
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@nl
P2093
P2860
P1476
Endogenous LXA4 circuits are d ...... in response to chronic injury.
@en
P2093
Aaron B Sullivan
Alexander J Leedom
Baiyan Dong
Denise Lau
Karsten Gronert
P2860
P356
10.2353/AJPATH.2010.090678
P407
P577
2009-12-11T00:00:00Z